瘤活性脱髓化病变的预后因素和多发性硬化症在病因学的差异性特征

Furkan Saridas1, Gizem Mesut1, Ceren Yayla Ceylan2

  • 1Bursa Uludağ University Medicine Faculty, Department of Neurology, Türkiye.

概括

早期识别瘤活性脱髓化病变 (TDL) 是关键. 急性发作和OCB2型表明MS,而高的CSF蛋白质表明其他非髓化疾病.